GEN Exclusives

More »

GEN Exclusives

More »

For full access to this article login to GEN Select now.

Jun 25, 2014

Low Patient Enrollment Threatens Cancer Trials

Answers include less red tape, more communication and coordination; study cites need for more accrual data.

Low Patient Enrollment Threatens Cancer Trials

Industry cost-cutting and fewer physicians participating in clinical trials are among the hurdles to cancer R&D listed in a recent report. [© michaeljung - Fotolia.com]

  • Just 2% to 5% of adult patients now enroll in U.S. cancer trials, according to estimates offered over the past 15 years—a distressingly ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

    • Do not put any letters or characters here if you are not a spy program.
    •  

Get GEN Select Access Now



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

Be sure to take the GEN Poll

Value-Pricing Cancer Drugs

Do you think all new cancer drugs awaiting approval should undergo value-pricing?

More »